What each role should evaluate
An owner should evaluate Red Rock on formulary fit and agreement pricing. Because Red Rock does not publish per-vial rates, the owner confirms landed cost on top SKUs with the clinic liaison before setting patient program prices. An operations lead should evaluate the SuiteRx workflow: how many portal sessions refill day requires, how rejections are surfaced, and how order status reaches patients.
A prescriber should evaluate clinical accuracy and speed: whether SIG entry is efficient, whether patient state is handled before submission, and how often clean orders are rejected downstream. Each role's risk differs, but they share one dependency — whether one compounder portal is enough when the clinic also routes lines elsewhere.